Effect of Estrogen Receptor on the Relationship Between HER2 Immunohistochemistry Score and Pathological Complete Response to Neoadjuvant Treatment in HER2-Positive Breast Cancer

• Asıl Yazarlar: Miaomiao Jia (Yazar), Haibo Yang (Yazar), Lihui Pan (Yazar), Jinnan Gao (Yazar), Fan Guo (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Hindawi-Wiley, 2024-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Conclusion: HER2 IHC 2+ may indicate a decreased tpCR rate, bpCR rate, and apCR rate to neoadjuvant treatment in HR-positive patients having HER2-positive breast cancer, but not in HR-negative patients.